NR 568 ADVANCED PHARMACOLOGY
Enhanced Midterm Study Guide • Weeks 1–4
Original exam-oriented review based on the public Stuvia preview and expanded with current clinical framing
Source reviewed: “Midterm Exam: NR 568 (NR568) | Latest 2023/2024 | Advanced Pharmacology for the
Adult-Gerontology Primary Care Nurse Practitioner Week 1–4.” Stuvia lists 21 pages and a 2023/2024 academic
year; its public preview emphasizes antibiotic classes and safety.
Study/copyright note: This PDF is newly written and does not reproduce paid or locked pages.
NR568 • Enhanced Original Advanced Pharmacology Study Guide Page 1
,1. Midterm Scope & Study Strategy
A related public NR568 midterm outline describes Weeks 1–4 as antimicrobial pharmacology and fungal/viral infections; bacterial
infections and antibiotic pharmacotherapy; gender-related, women's, men's and transgender health; and urinary conditions. It
emphasizes generic drug names, mechanisms, PK/PD, indications, adverse effects, contraindications, monitoring, and
pregnancy/breastfeeding considerations. ■cite■turn0search2■
• For every drug: class → mechanism → indication → major adverse effects → contraindications/cautions → monitoring →
teaching → interactions.
• Use patient factors—renal/hepatic function, age, pregnancy, comorbidities, allergies—to eliminate unsafe choices.
• Distinguish empiric from targeted therapy and always consider antimicrobial stewardship.
• If an older study-bank statement conflicts with current evidence, use current guidance and your course's required resources.
NP-level mindset: The correct answer is often the drug that fits the organism AND the patient, not simply the broadest-spectrum
drug.
NR568 • Enhanced Original Advanced Pharmacology Study Guide Page 2
, 2. Core Pharmacology & Antimicrobial Stewardship
PK vs PD
• Pharmacokinetics (PK): what the body does to the drug—absorption, distribution, metabolism, elimination.
• Pharmacodynamics (PD): what the drug does to the body/target—drug effect, exposure-response, and toxicity.
• Half-life helps predict accumulation and dosing interval.
• Renal impairment can increase exposure to drugs cleared by the kidneys.
Empiric vs targeted therapy
Empiric therapy begins before the pathogen and susceptibility profile are fully known. Selection should consider likely organisms,
infection site, severity, local resistance, prior antimicrobial exposure, allergies, renal/hepatic function, and patient-specific risks.
Targeted therapy uses microbiology and clinical response to narrow or change treatment when appropriate.
Stewardship
Antimicrobial stewardship seeks effective treatment while reducing unnecessary exposure, adverse effects, and resistance. A
2026 IDSA-endorsed stewardship guidance document applies these principles across acute, outpatient, and long-term-care
settings. ■cite■turn1search7■
NR568 • Enhanced Original Advanced Pharmacology Study Guide Page 3
Enhanced Midterm Study Guide • Weeks 1–4
Original exam-oriented review based on the public Stuvia preview and expanded with current clinical framing
Source reviewed: “Midterm Exam: NR 568 (NR568) | Latest 2023/2024 | Advanced Pharmacology for the
Adult-Gerontology Primary Care Nurse Practitioner Week 1–4.” Stuvia lists 21 pages and a 2023/2024 academic
year; its public preview emphasizes antibiotic classes and safety.
Study/copyright note: This PDF is newly written and does not reproduce paid or locked pages.
NR568 • Enhanced Original Advanced Pharmacology Study Guide Page 1
,1. Midterm Scope & Study Strategy
A related public NR568 midterm outline describes Weeks 1–4 as antimicrobial pharmacology and fungal/viral infections; bacterial
infections and antibiotic pharmacotherapy; gender-related, women's, men's and transgender health; and urinary conditions. It
emphasizes generic drug names, mechanisms, PK/PD, indications, adverse effects, contraindications, monitoring, and
pregnancy/breastfeeding considerations. ■cite■turn0search2■
• For every drug: class → mechanism → indication → major adverse effects → contraindications/cautions → monitoring →
teaching → interactions.
• Use patient factors—renal/hepatic function, age, pregnancy, comorbidities, allergies—to eliminate unsafe choices.
• Distinguish empiric from targeted therapy and always consider antimicrobial stewardship.
• If an older study-bank statement conflicts with current evidence, use current guidance and your course's required resources.
NP-level mindset: The correct answer is often the drug that fits the organism AND the patient, not simply the broadest-spectrum
drug.
NR568 • Enhanced Original Advanced Pharmacology Study Guide Page 2
, 2. Core Pharmacology & Antimicrobial Stewardship
PK vs PD
• Pharmacokinetics (PK): what the body does to the drug—absorption, distribution, metabolism, elimination.
• Pharmacodynamics (PD): what the drug does to the body/target—drug effect, exposure-response, and toxicity.
• Half-life helps predict accumulation and dosing interval.
• Renal impairment can increase exposure to drugs cleared by the kidneys.
Empiric vs targeted therapy
Empiric therapy begins before the pathogen and susceptibility profile are fully known. Selection should consider likely organisms,
infection site, severity, local resistance, prior antimicrobial exposure, allergies, renal/hepatic function, and patient-specific risks.
Targeted therapy uses microbiology and clinical response to narrow or change treatment when appropriate.
Stewardship
Antimicrobial stewardship seeks effective treatment while reducing unnecessary exposure, adverse effects, and resistance. A
2026 IDSA-endorsed stewardship guidance document applies these principles across acute, outpatient, and long-term-care
settings. ■cite■turn1search7■
NR568 • Enhanced Original Advanced Pharmacology Study Guide Page 3
